Kenneth Bate, Director at CUBIST PHARMACEUTICALS INC (CBST), sold 2,500 shares at $54.95 ($137K) on 2013-06-03, disclosed to the SEC on 2013-06-03.
Seasonal sale ($137k) by Director — this insider has traded CBST in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| MDGL | SELL | 2025-02-28 | $14.0M | — | Filing → |
| MDGL | SELL | 2024-04-03 | $16.0M | — | Filing → |
| CBST | SELL | 2014-02-04 | $451K | — | Filing → |